| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: chemotherapy protocol consisting of above compounds; used for treatment of Hodgkin's disease
Also Known As:| 1. | B-Cell Lymphoma (Lymphoma, B Cell)
01/01/1989
- "The ABEP regimen proved to be effective in T-cell as well as B-cell lymphoma. "
Order ALL the reference details at left... |
| 2. | Lymphoma (Lymphomas)
01/01/1989
- "The ABEP regimen was effective in the treatment of patients with recurrent or refractory lymphoma, enabling hope for long-term survival in the majority of CR cases."
Order ALL the reference details at left... |
| 3. | Non-Hodgkin Lymphoma (Lymphosarcoma)
04/01/1986
- "Twelve patients with fresh non-Hodgkin's lymphoma stage IV were treated with ABEP regimen. "
04/01/1986 - "Nineteen patients with refractory non-Hodgkin's lymphoma were treated with a combination of N4-behenoyl-1-beta-D-arabinofuranosylcytosine (150-200 mg/m2), aclacinomycin (15 mg/m2), etoposide (70 mg/m2 i.v. or 100 mg/m2 p.o) and prednisolone (20 mg/m2) (ABEP regimen). " Order ALL the reference details at left... |
| 1. | Prednisolone (Predate)
|
| 2. | Etoposide (VP 16)
|
| 3. | aclacinomycins
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |